Evidence supporting the use of: Astragalin
For the health condition: Parkinson's Disease

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 1

Astragalin is a natural flavonoid compound found in various plants, including Kaempferia galanga and green tea. While Astragalin has been studied for a variety of pharmacological effects, its use in Parkinson’s Disease (PD) is not rooted in traditional medicine practices, but rather in recent preclinical research. A few animal and cell studies have indicated that Astragalin may have neuroprotective properties relevant to PD, such as reducing oxidative stress, inhibiting neuroinflammation, and protecting dopaminergic neurons from toxin-induced injury. For example, a 2022 study in a mouse model of PD suggested that Astragalin could attenuate motor deficits and dopaminergic neuron loss, likely via its antioxidant effects and modulation of signaling pathways involved in neuronal survival.1 However, these findings are preliminary and have not yet been translated into robust clinical trials in humans. There are currently no well-designed human studies or regulatory approvals supporting Astragalin’s use for PD. Thus, while there is some scientific basis for further research, the evidence remains weak (rated 1/5) and should not be considered validated or recommended for clinical use at this time.

1. Zhang W, et al. "Astragalin Attenuates Neurodegeneration in MPTP-Induced Parkinson's Disease Models via Suppressing Oxidative Stress and Neuroinflammation." Neurochemical Research. 2022.

More about Astragalin
More about Parkinson's Disease

Products containing Astragalin

We currently have no products on Vitabase that contain this ingredient.